These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Intracavernous injections for impotence. Med Lett Drugs Ther; 1987 Oct 23; 29(751):95-6. PubMed ID: 3670212 [No Abstract] [Full Text] [Related]
3. The use of vasoactive agents in the treatment of erectile impotence. Fried FA. N C Med J; 1990 Jun 23; 51(6):295-6. PubMed ID: 2366889 [No Abstract] [Full Text] [Related]
4. Diagnostic and therapeutic technology assessment. Vasoactive intracavernous pharmacotherapy for impotence: papaverine and phentolamine. JAMA; 1990 Aug 08; 264(6):752-4. PubMed ID: 2374280 [No Abstract] [Full Text] [Related]
5. Physiological considerations in radionuclide imaging of the penis during impotence therapy. Chaudhuri TK, Fink S, Burger RH, Netto IC, Palmer JD. Am J Physiol Imaging; 1989 Aug 08; 4(2):75-80. PubMed ID: 2667586 [Abstract] [Full Text] [Related]
6. Prostaglandin E1 versus phentolamine/papaverine for the treatment of erectile impotence: a double-blind comparison. Lee LM, Stevenson RW, Szasz G. J Urol; 1989 Mar 08; 141(3):549-50. PubMed ID: 2918589 [Abstract] [Full Text] [Related]
11. [Intracavernous injection of vasoactive drugs for treating erectile impotence]. Yasumoto R, Asakawa M, Kawashima H, Yoshimura R, Maekawa T, Kashiwara N, Tanaka H, Nishio S. Hinyokika Kiyo; 1988 Feb 05; 34(2):301-4. PubMed ID: 2454019 [Abstract] [Full Text] [Related]
12. Penile response to intracavernosal vasoactive intestinal polypeptide alone and in combination with other vasoactive agents. Kiely EA, Bloom SR, Williams G. Br J Urol; 1989 Aug 05; 64(2):191-4. PubMed ID: 2765789 [Abstract] [Full Text] [Related]
13. Treatment of prolonged or priapistic erections following intracavernosal papaverine therapy. Padma-Nathan H, Goldstein I, Krane RJ. Semin Urol; 1986 Nov 05; 4(4):236-8. PubMed ID: 3797893 [No Abstract] [Full Text] [Related]
14. Penile self-injection for impotence in patients after radical cystectomy. Rodilla F, Fuentes MD, Chuan P, Ferriols F, Magraner J. J Clin Pharm Ther; 1994 Dec 05; 19(6):359-60. PubMed ID: 7876367 [No Abstract] [Full Text] [Related]
15. [Intracavernous pharmacotherapy for organic impotence in the elderly]. Richter S, Shalev M, Nissenkorn I. Harefuah; 1990 Aug 05; 119(3-4):66-7. PubMed ID: 2227669 [Abstract] [Full Text] [Related]
16. Pharmacologic erection program for the treatment of male impotence. Trapp JD. South Med J; 1987 Apr 05; 80(4):426-7. PubMed ID: 2436316 [Abstract] [Full Text] [Related]
17. Intracavernous pharmacotherapy for impotence: selection of appropriate agent and dose. von Heyden B, Donatucci CF, Kaula N, Lue TF. J Urol; 1993 May 05; 149(5 Pt 2):1288-90. PubMed ID: 8479018 [Abstract] [Full Text] [Related]
18. Effect of multidose intracorporeal injection and audiovisual sexual stimulation in vasculogenic impotence. Katlowitz N, Albano GJ, Patsias G, Golimbu M, Morales P. Urology; 1993 Dec 05; 42(6):695-7. PubMed ID: 8256402 [Abstract] [Full Text] [Related]
19. [Action of vasoactive drugs in male sexual impotence]. Morales JC, Elizondo B. Arch Esp Urol; 1989 Dec 05; 42(9):900-4. PubMed ID: 2624491 [Abstract] [Full Text] [Related]
20. Intracavernous drug-induced erections in the management of male erectile dysfunction: experience with 100 patients. Sidi AA, Cameron JS, Duffy LM, Lange PH. J Urol; 1986 Apr 05; 135(4):704-6. PubMed ID: 2421014 [Abstract] [Full Text] [Related] Page: [Next] [New Search]